Semaglutide has emerged as a groundbreaking medication, transforming the landscape of healthcare for those with type 2 diabetes, obesity, and cardiovascular risk factors. Initially developed for diabetes management, semaglutide belongs to a class of drugs known as GLP-1 receptor agonists, which mimic the natural hormone GLP-1 (glucagon-like peptide-1). This hormone https://d365-finance-and-operatio54297.full-design.com/semaglutide-a-breakthrough-in-diabetes-weight-loss-and-heart-health-73594372